Archive · 12 Nov 2025
Indian Health Supplement Startups Battle Trust Deficit with Clinical Trials and Transparency
Imagine a bunch of new companies making vitamins and special powders to help people feel better or look a certain way.
Some people try them and feel great, like Fahad who lost weight with a supplement.
But other people, like Ryan, don't see any changes, and sometimes doctors worry these supplements might even cause harm, like liver problems.
This is because it's not always easy to know if these supplements are truly effective or safe, and sometimes companies rush products to market without enough testing.
Some companies are now trying to fix this by doing their own science experiments (clinical trials) to prove their products work, just like real medicines do.
They are also trying to be more open about what's inside their products and how they are made.
Others believe that stricter rules, like those for medicines, are needed to make sure everything is safe and works as promised.
The goal is to make people trust these health products again.
India's health supplement industry is booming post-COVID-19, driven by rising health awareness and D2C startups.
Despite significant investment, the industry faces a major trust deficit due to inconsistent consumer experiences and skepticism from healthcare providers.
Regulatory gaps allow nutraceuticals to be classified as food, bypassing stricter drug regulations and mandatory clinical studies.
Many startups are investing in clinical trials and transparent testing to build credibility and differentiate themselves.
Companies are adopting customer-centric approaches, focusing on problem-solving blends and physician endorsements to gain trust.
- Who
- Indian health supplement startups, consumers, healthcare providers, contract manufacturers, and regulatory bodies.
- What
- Addressing a significant trust deficit in the health supplement industry, with startups employing strategies like clinical trials, transparency, and customer education to build credibility.
- When
- The industry saw a fillip post-COVID-19 pandemic, with increasing investment and new entrants; efforts to build trust are ongoing.
- Where
- Primarily India, with a focus on direct-to-consumer (D2C) models and increasing investments.
- Why
- To overcome consumer skepticism, inconsistent product experiences, and doubts from healthcare professionals, thereby establishing long-term viability and growth in a rapidly expanding market.
Skeptical Consumers and Doctors
Supplement Companies Aiming for Credibility
Efficacy and Safety Concerns
Skeptical Consumers and Doctors
Many consumers and healthcare providers are wary of health supplements due to inconsistent experiences, potential side effects like liver injury, and lack of rigorous scientific evidence. They question the actual benefits of 'magic' powders and blends, especially when marketed aggressively.
Supplement Companies Aiming for Credibility
Startups are investing in clinical trials, isolating active compounds, and standardizing ingredients to scientifically prove the efficacy and safety of their products, aiming to become as trusted as pharmaceutical companies.
Regulatory Oversight
Skeptical Consumers and Doctors
The current regulatory framework, classifying nutraceuticals as food products under FSSAI, allows for a 'thin line' with drug regulations. This ease, combined with the reliance on pre-approved ingredients and lack of mandatory clinical studies, leads to a trust deficit.
Supplement Companies Aiming for Credibility
Companies are advocating for higher standards and more stringent regulatory requirements, believing that ingestible products should have a comparable burden of proof for safety and efficacy as allopathic drugs.
Business Models and Transparency
Skeptical Consumers and Doctors
Many new entrants are criticized for prioritizing marketing and quick business opportunities over genuine understanding of nutraceuticals, often relying on white-labeling and third-party manufacturers without rigorous quality control or transparency.
Supplement Companies Aiming for Credibility
Reputable startups are focusing on in-house R&D, transparency in testing (e.g., batch testing results shared with customers), customer-centric approaches, and building trust through consistent results and word-of-mouth.
- Nutraceutical Market Size (Projected)
- $8 billion by 2025 (IMARC estimate)
- Active Startups
- 478 (Tracxn data)
- Investment in Startups
- Nearly $635 million across 222 funding rounds
- Investment This Year
- Over $52 million
- Kapiva Funding
- $28 million capital infusion
- Reliance Industries Acquisition
- Majority stake in Naturedge Beverages (Shunya functional beverage)
- HUL Acquisition
- Majority stake in OZiva (plant-based nutraceuticals)
- Marico Acquisition
- Majority stake in Plix (plant-based nutraceuticals)